Evidence map›Paper›PMID 38995644›Full record

ArticleJAMA network open2024

Neighborhood Disadvantage and Prostate Tumor RNA Expression of Stress-Related Genes.

Joseph Boyle, Jessica Yau, Jimmie L Slade, Derrick A Butts, Yuji Zhang, Teklu B Legesse, Ashley Cellini, Kimberly Clark, Jong Y Park, Jessica Wimbush and 7 more

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. L-SOLCO Pilot Study: Examining Allostatic Load and Cancer Treatment Disparities.Journal of racial and ethnic health disparities · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Joseph BoyleDepartment of Biostatistics, Virginia Commonwealth University, Richmond.
Jessica YauDepartment of Cellular and Molecular Biomedical Science, University of Maryland School of Medicine, Baltimore.
Jimmie L SladeMaryland Community Health Engagement Partnership, Upper Marlboro.
Derrick A ButtsProstate Health Matters, Washington, DC.
Yuji ZhangDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore.
Teklu B LegesseDepartment of Pathology, University of Maryland School of Medicine, Baltimore.
Ashley CelliniPathology Biorepository Shared Service, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore.
Kimberly ClarkPathology Biorepository Shared Service, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore.
Jong Y ParkDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida.
Jessica WimbushUniversity of Maryland Greenebaum Comprehensive Cancer Center Tumor Registry, Baltimore.
Nicholas AmbulosProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore.
Jing YinProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore.
Arif HussainProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore.
Eberechukwu OnukwughaProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore.
Cheryl L KnottProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore.
David C WheelerDepartment of Biostatistics, Virginia Commonwealth University, Richmond.
Kathryn Hughes BarryDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore.

Funding

QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Training Program in Cancer Prevention and Control and Cancer Health Equity (CPC-CHE)T32CA093423 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Bernard F Fuemmeler, Oxana G Palesh · 2018 to 2026
$3.0M
Epigenomic and transcriptomic markers of aggressive prostate cancer among African American menK07CA230182 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, KATHRYN HUGHES · 2018 to 2023
$827k
NCATS NIH HHS UL1 TR003098NCI NIH HHS K07 CA230182NCI NIH HHS P30 CA134274NCI NIH HHS T32 CA093423
6 · The paper itself

Abstract

Importance: African American men experience greater prostate cancer incidence and mortality than White men. Growing literature supports associations of neighborhood disadvantage, which disproportionately affects African American men, with aggressive prostate cancer; chronic stress and downstream biological impacts (eg, increased inflammation) may contribute to these associations. Objective: To examine whether several neighborhood disadvantage metrics are associated with prostate tumor RNA expression of stress-related genes. Design, Setting, and Participants: This cross-sectional study leveraged prostate tumor transcriptomic data for African American and White men with prostate cancer who received radical prostatectomy at the University of Maryland Medical Center between August 1992 and January 2021. Data were analyzed from May 2023 to April 2024. Exposures: Using addresses at diagnosis, 2 neighborhood deprivation metrics (Area Deprivation Index [ADI] and validated bayesian Neighborhood Deprivation Index) as well as the Racial Isolation Index (RI) and historical redlining were applied to participants' addresses. Self-reported race was determined using electronic medical records. Main Outcomes and Measures: A total of 105 stress-related genes were evaluated with each neighborhood metric using linear regression, adjusting for race, age, and year of surgery. Genes in the Conserved Transcriptional Response to Adversity (CTRA) and stress-related signaling genes were included. Results: A total of 218 men (168 [77%] African American, 50 [23%] White) with a median (IQR) age of 58 (53-63) years were included. African American participants experienced greater neighborhood disadvantage than White participants (median [IQR] ADI, 115 [100-130] vs 92 [83-104]; median [IQR] RI, 0.68 [0.34-0.87] vs 0.11 [0.06-0.14]). ADI was positively associated with expression for 11 genes; HTR6 (serotonin pathway) remained significant after multiple-comparison adjustment (β = 0.003; SE, 0.001; P < .001; Benjamini-Hochberg q value = .01). Several genes, including HTR6, were associated with multiple metrics. We observed higher expression of 5 proinflammatory genes in the CTRA with greater neighborhood disadvantage (eg, CXCL8 and ADI, β = 0.008; SE, 0.003; P = .01; q value = .21). Conclusions and Relevance: In this cross-sectional study, the expression of several stress-related genes in prostate tumors was higher among men residing in disadvantaged neighborhoods. This study is one of the first to suggest associations of neighborhood disadvantage with prostate tumor RNA expression. Additional research is needed in larger studies to replicate findings and further investigate interrelationships of neighborhood factors, tumor biology, and aggressive prostate cancer to inform interventions to reduce disparities.

Indexed as

Black or African AmericanProstatic NeoplasmsWhiteAgedCross-Sectional StudiesHumansMaleMarylandMiddle AgedNeighborhood CharacteristicsProstatectomyResidence CharacteristicsStress, Psychological

Identifiers

PMID38995644
PMCPMC11245728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.